Skip to main content

Vicente García-Patos Briones

Institutions of which they are part

Head of group
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Vicente García-Patos Briones

Institutions of which they are part

Head of group
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Tumor dependent immune evasive mechanisms in melanoma

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Eva Muñoz Couselo, Tumor dependent immune evasive mechanisms in melanoma, Tumor dependent immune evasive mechanisms in melanoma
Funding agency: Instituto de Salud Carlos III
Funding: 321250
Reference: PI23/00428
Duration: 01/01/2024 - 31/12/2026

Recerca biomèdica and melanomes mod anim i càncer

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Carlos González Cruz, Vicente García-Patos Briones, Eva Muñoz Couselo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00653
Duration: 01/01/2022 - 30/06/2025

Oncogene-mediated intratumoral immune-cell populations at different organs as biomarkers of immunotherapy response

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Sara Garcia Ortega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 341220
Reference: PI20/00384
Duration: 01/01/2021 - 30/04/2024

Estudio de la cooperación de la vía de estrés (MAPK14) en el desarrollo, progresión y regulación de la respuesta inmune intra-tumoral en melanoma con fines terapéuticos

IP: Juan Angel Recio Conde
Collaborators: Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI17/00043
Duration: 01/01/2018 - 30/06/2021

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Ainhoa Perez Travesedo

Ainhoa Perez Travesedo

Fundraising Unit
Communication Directorate
Read more
Guillem Navarro Bonet

Guillem Navarro Bonet

Commercial and Academic Clinical Research
Read more
Maria del Carmen Llorente Olmedo

Maria del Carmen Llorente Olmedo

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
María López Berral

María López Berral

Research technician
Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.